Loading clinical trials...

Stellate Ganglion Blockade in Corona Virus 2019 (COVID-19) Positive Patients | Clinical Trials | Clareo Health

TERMINATEDPhase 1NCT04445337

Stellate Ganglion Blockade in Corona Virus 2019 (COVID-19) Positive Patients

This study will establish the safety and efficacy of using stellate ganglion blocks in patients with acute respiratory distress syndrome (ARDS) due to COVID-19 disease.

Lead sponsor: University of Nebraska•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Clinical Decision Support Tool in PARDS Pilot Study

NCT04068012 · Ventilation Therapy; Complications, Ventilator-Induced Lung Injury, and more

RECRUITINGNA

Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19

NCT06871293 · Long COVID-19 Syndrome, COVID 19, and more

RECRUITING

Trunk Inclination, Positive End-expiratory Pressure, and Lung Recruitability

NCT07504731 · Acute Respiratory Distress Syndrome (ARDS)

RECRUITINGPhase 2

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)

NCT06703073 · Acute Respiratory Distress Syndrome (ARDS), ARDS, and more

RECRUITINGPhase 2

Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial

NCT07123961 · Acute Respiratory Distress Syndrome (ARDS), Ventilator Management, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 20, 2025Terms

Trial snapshot

StatusTERMINATED

PhasePHASE1

Enrollment1

Start dateNov 2020

Last updatedJan 20, 2025

Condition

COVID 19 ARDS

Locations shown

University of Nebraska Medical Center

Omaha, Nebraska

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 20, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions